Pneumocystis: immune recognition and evasion.

[1]  C. Beard,et al.  Current Epidemiology of Pneumocystis Pneumonia , 2004, Emerging infectious diseases.

[2]  A. Limper,et al.  Pneumocystis pneumonia. , 2004, The New England journal of medicine.

[3]  M. Lasbury,et al.  Effect of Bronchoalveolar Lavage Fluid from Pneumocystis carinii- Infected Hosts on Phagocytic Activity of Alveolar Macrophages , 2004, Infection and Immunity.

[4]  S. Gordon,et al.  Alveolar Macrophage–mediated Killing of Pneumocystis carinii f. sp. muris Involves Molecular Recognition by the Dectin-1 β-Glucan Receptor , 2003, The Journal of experimental medicine.

[5]  M. Nussenzweig,et al.  Absence of the Macrophage Mannose Receptor in Mice Does Not Increase Susceptibility to Pneumocystis carinii Infection In Vivo , 2003, Infection and Immunity.

[6]  G. Fink,et al.  Lung Epithelial Cells and Extracellular Matrix Components Induce Expression of Pneumocystis carinii STE20, a Gene Complementing the Mating and Pseudohyphal Growth Defects of ste20 Mutant Yeast , 2003, Infection and Immunity.

[7]  V. Puri,et al.  Pneumocystis carinii Cell Wall β-Glucans Initiate Macrophage Inflammatory Responses through NF-κB Activation* , 2003, Journal of Biological Chemistry.

[8]  T. Wright,et al.  Characterization of Transmission of Pneumocystis carinii f. sp. muris through Immunocompetent BALB/c Mice , 2003, Infection and Immunity.

[9]  J. Standing,et al.  Pneumocystis carinii Cell Wall β-Glucan Induces Release of Macrophage Inflammatory Protein-2 from Alveolar Epithelial Cells via a Lactosylceramide-mediated Mechanism* , 2003, The Journal of Biological Chemistry.

[10]  V. Morrison.  The role of caspofungin and the echinocandins in the antifungal armamentarium. , 2002, Current opinion in investigational drugs.

[11]  L. Mele,et al.  Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres , 2002, British journal of haematology.

[12]  J. Stringer,et al.  Genetics of Surface Antigen Expression inPneumocystis carinii , 2001, Infection and Immunity.

[13]  C. Douglas.  Fungal β(1,3)-d-glucan synthesis , 2001 .

[14]  I. Fraser,et al.  Pneumocystis carinii enhances soluble mannose receptor production by macrophages. , 2000, Microbes and infection.

[15]  J. Standing,et al.  Isolated Pneumocystis carinii Cell Wall Glucan Provokes Lower Respiratory Tract Inflammatory Responses1 , 2000, The Journal of Immunology.

[16]  M. Cushion,et al.  Summary of Pneumocystis Research Presented at the 7th International Workshop on Opportunistic Protists , 1999, The Journal of eukaryotic microbiology.

[17]  Lundgren,et al.  Pneumocystis carinii major surface glycoprotein induces interleukin‐8 and monocyte chemoattractant protein‐1 release from a human alveolar epithelial cell line , 1999, European journal of clinical investigation.

[18]  J. Wagner,et al.  Interaction of rat Pneumocystis carinii and rat alveolar epithelial cells in vitro. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[19]  P. Walzer,et al.  The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii. , 1997, Biochemistry.

[20]  J. Stringer,et al.  Pneumocystis carinii: what is it, exactly? , 1996, Clinical microbiology reviews.

[21]  S. Oka,et al.  (1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia , 1996, Clinical and diagnostic laboratory immunology.

[22]  J. Standing,et al.  Pneumocystis carinii glycoprotein A binds macrophage mannose receptors , 1995, Infection and immunity.

[23]  J. Standing,et al.  Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells , 1993, Infection and immunity.

[24]  C. Haidaris,et al.  Pneumocystis carinii is not universally transmissible between mammalian species , 1993, Infection and immunity.

[25]  J. Standing,et al.  Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. , 1993, Journal of immunology.

[26]  A. Limper,et al.  Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. , 1991, The Journal of laboratory and clinical medicine.

[27]  Y. Matsumoto,et al.  Yeast glucan of Pneumocystis carinii cyst wall: an excellent target for chemotherapy. , 1991, The Journal of protozoology.

[28]  A. Wakefield,et al.  Mitochondrial gene sequences show fungal homology for Pneumocystis carinii , 1991, Molecular microbiology.

[29]  D. Williams,et al.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor , 1991, Nature.

[30]  M. Cushion,et al.  Analysis of Pneumocystis carinii cyst wall. II. Sugar composition. , 1990, The Journal of protozoology.

[31]  J. Shellito,et al.  A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. , 1990, The Journal of clinical investigation.

[32]  J. Phair,et al.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. , 1990, The New England journal of medicine.

[33]  T. F. Smith,et al.  Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS , 1989 .

[34]  T. Tegoshi,et al.  Yeast glucan in the cyst wall of Pneumocystis carinii. , 1989, The Journal of protozoology.

[35]  L. Ballou,et al.  Purification and initial characterization of a ferret Pneumocystis carinii surface antigen. , 1988, The Journal of infectious diseases.

[36]  M. Sogin,et al.  Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi , 1988, Nature.

[37]  P. Walzer.  Attachment of microbes to host cells: relevance of Pneumocystis carinii. , 1986, Laboratory investigation; a journal of technical methods and pathology.